Noninvasive revascularization by enhanced external counterpulsation: a case study and literature review.

Nearly 8 million people in the United States suffer from symptoms of coronary artery disease (CAD). Unfortunately, the population of patients with ischemic coronary disease that is not readily amenable to surgical or percutaneous revascularization continues to grow. For patients who are not candidates for standard revascularization procedures and in whom aggressive medical therapy fails to control symptoms, enhanced external counterpulsation (EECP) is a new, noninvasive outpatient method to improve quality of life by decreasing ischemic symptoms and permit increased activity. We report the case of a 56-year-old woman with severe, symptomatic CAD receiving maximal medical therapy who underwent a course of EECP therapy because she was not a good candidate for other forms of revascularization. She demonstrated dramatic improvement in her anginal symptoms and complete resolution of myocardial ischemia on repeat nuclear stress imaging. This case suggests that EECP is a safe and effective method for reducing symptoms of myocardial ischemia in patients for whom standard percutaneous or surgical revascularization is not suitable treatment.

[1]  R. Nohara,et al.  Enhanced external counterpulsation improved myocardial perfusion and coronary flow reserve in patients with chronic stable angina; evaluation by(13)N-ammonia positron emission tomography. , 2001, European heart journal.

[2]  O. Frazier,et al.  Transmyocardial revascularization with a carbon dioxide laser in patients with end-stage coronary artery disease. , 1999, The New England journal of medicine.

[3]  Robert D. Dowling,et al.  Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. , 1999, The New England journal of medicine.

[4]  J. Isner,et al.  Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. , 1999, The Annals of thoracic surgery.

[5]  R. Nesto,et al.  The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. , 1999, Journal of the American College of Cardiology.

[6]  B. Chaitman,et al.  Analyses of coronary graft patency after aprotinin use: results from the International Multicenter Aprotinin Graft Patency Experience (IMAGE) trial. , 1998, The Journal of thoracic and cardiovascular surgery.

[7]  M. Zenati,et al.  MIDCAB characteristics and results: the CardioThoracic Systems (CTS) registry. , 1998, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[8]  Regina M. Hardison,et al.  Myocardial infarction and cardiac mortality in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial. , 1997, Circulation.

[9]  P. den Heijer,et al.  Minimally invasive coronary artery bypass grafting versus coronary angioplasty for isolated type C stenosis of the left anterior descending artery. , 1997, The Journal of thoracic and cardiovascular surgery.

[10]  RITA-2 trial participants Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial , 1997, The Lancet.

[11]  M. Mariani,et al.  Improved method for direct coronary grafting without CPB via anterolateral small thoracotomy. , 1997, The Annals of thoracic surgery.

[12]  J G Grandjean,et al.  Video-assisted minimally invasive coronary operations without cardiopulmonary bypass: a multicenter study. , 1996, The Journal of thoracic and cardiovascular surgery.

[13]  T. Peterson,et al.  Fluid shear stress stimulates mitogen-activated protein kinase in endothelial cells. , 1995, Circulation research.

[14]  P. Cohn,et al.  Three-year sustained benefit from enhanced external counterpulsation in chronic angina pectoris. , 1995, The American journal of cardiology.

[15]  M. Kasim,et al.  Enhanced External Counterpulsation in the Treatment and Rehabilitation of Coronary Patients in Indonesia , 1995 .

[16]  H. Hillege,et al.  Efficacy of spinal cord stimulation as adjuvant therapy for intractable angina pectoris: a prospective, randomized clinical study. Working Group on Neurocardiology. , 1994, Journal of the American College of Cardiology.

[17]  Michael C. Petch,et al.  Effect of Transcutaneous Electrical Nerve Stimulation on Coronary Blood Flow , 1994, Circulation.

[18]  K. Pritchard,et al.  Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. , 1994, Circulation research.

[19]  P. Cohn,et al.  Efficacy of enhanced external counterpulsation in the treatment of angina pectoris. , 1992, The American journal of cardiology.

[20]  P. Stone,et al.  Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group. , 1990, Circulation.

[21]  C. Shub Stable angina pectoris: 3. Medical treatment. , 1990, Mayo Clinic proceedings.

[22]  S Glagov,et al.  Shear stress regulation of artery lumen diameter in experimental atherogenesis. , 1987, Journal of vascular surgery.

[23]  H. Kambic,et al.  Sequential external counterpulsation (SECP) in China. , 1983, Transactions - American Society for Artificial Internal Organs.

[24]  R. Gorlin,et al.  A new therapeutic approach to acute coronary occlusion: II. Opening dormant coronary collateral channels by counterpulsation , 1963 .

[25]  W J KOLFF,et al.  Diastolic balloon pumping (with carbon dioxide) in the aorta--a mechanical assistance to the failing circulation. , 1962, American heart journal.

[26]  A. Kantrowitz Experimental augmentation of coronary flow by retardation of the arterial pressure pulse. , 1953, Surgery.